Download PDF
Horm Metab Res 2005; 37: 17-25
DOI: 10.1055/s-2005-861365
Review
© Georg Thieme Verlag KG Stuttgart · New York

The Use of Transgenic Animals in the Study of Diabetic Kidney Disease

L.  Wogensen1 , S.  Krag1 , Q.  Chai1 , T.  Ledet1
  • 1 Research Laboratory of Biochemical Pathology, Aarhus University Hospital, 44 Nørrebrogade, Building 3B, 8000 Aarhus C, Denmark
Further Information

Publication History

Received 7 December 2004

Accepted after Revision 28 February 2005

Publication Date:
25 May 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Diabetic nephropathy is one of the most common diseases leading to fibrosis and end-stage renal disease (ESRD) world wide. Under normal conditions, a delicate equilibrium exists between synthesis, composition, and removal of extracellular matrix (ECM). If this is disturbed, ECM accumulation and fibrosis may result. The fragile balance between synthesis and removal of ECM is crucial for the prognosis of glomerular as well as interstitial pathological processes. Some features may favor ECM accumulation and progression to ESRD (dialysis and transplantation), whereas other elements may favor ECM removal and resolution (recovery). Pathogenetic mechanisms and the cellular sources of ECM in the glomerular basement membrane as well as in the tubulointerstitial space are still under investigation. Among several growth factors, transforming growth factor β1 (TGF-β1) plays a major role. We consider the use of living animals necessary for our understanding of the complex biological processes that occur during the development of ESRD. The present review will discuss the glomerular as well as interstitial accumulation of ECM and the use of transgenic animals in studying the pathogenetic mechanisms with special emphasis on diabetic kidney disease and TGF-β1.

Key words

Transforming growth factor β1 - Extracellular matrix - Diabetes - Transgenic models

References

  • 1 Borch Johnsen K. The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach.  Dan Med Bull. 1989;  36 336-348
    PubMedSearch in Google Scholar
  • 2 Andresen J L, Rasmussen L M, Ledet T. Diabetic macroangiopathy and atherosclerosis.  Diabetes. 1996;  45 Suppl 3 S91-S94
    PubMedSearch in Google Scholar
  • 3 Rasmussen L M, Heickendorff L. Accumulation of fibronectin in aortas from diabetic patients. A quantitative immunohistochemical and biochemical study.  Lab Invest. 1989;  61 440-446
    PubMedSearch in Google Scholar
  • 4 Rasmussen L M, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation.  Diabetologia. 1993;  36 445-453
    CrossrefPubMedSearch in Google Scholar
  • 5 Heickendorff L, Ledet T, Rasmussen L M. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque.  Diabetologia. 1994;  37 286-292
    PubMedSearch in Google Scholar
  • 6 Bunn H F. Nonenzymatic glycosylation of protein: relevance to diabetes.  Am J Med. 1981;  70 325-330
    CrossrefPubMedSearch in Google Scholar
  • 7 Flyvbjerg A. The Role of Insulin-like Growth Factor I in Initial Renal Hypertrophy in Experimental Diabetes. 1993. Aarhus University. Ref Type: Thesis/Dissertation. 
  • 8 Suzuki D, Yagame M, Kim Y, Sakai H, Mauer M. Renal in situ hybridization studies of extracellular matrix related molecules in type 1 diabetes mellitus.  Nephron. 2002;  92 564-572
    CrossrefPubMedSearch in Google Scholar
  • 9 Abrass C K, Spicer D, Berfield A K, St John P L, Abrahamson D R. Diabetes induces changes in glomerular development and laminin-beta 2 (s-laminin) expression.  Am J Pathol. 1997;  151 1131-1140
    PubMedSearch in Google Scholar
  • 10 Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.  Am J Pathol. 1991;  139 889-899
    PubMedSearch in Google Scholar
  • 11 Yang C W, Vlassara H, Peten E P, He C J, Striker G E, Striker L J. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.  Proc Natl Acad Sci U S A. 1994;  91 9436-9440
    PubMedSearch in Google Scholar
  • 12 Doi T, Vlassara H, Kirstein M, Yamada Y, Striker G E, Striker L J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.  Proc Natl Acad Sci U S A. 1992;  89 2873-2877
    PubMedSearch in Google Scholar
  • 13 Sinniah R, Khan T N. Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases.  Ultrastruct Pathol. 1999;  23 359-368
    PubMedSearch in Google Scholar
  • 14 Eddy A A. Molecular basis of renal fibrosis.  Pediatr Nephrol. 2000;  15 290-301
    CrossrefPubMedSearch in Google Scholar
  • 15 Norman J T, Fine L G. Progressive renal disease: fibroblasts, extracellular matrix, and integrins.  Exp Nephrol. 1999;  7 167-177
    CrossrefPubMedSearch in Google Scholar
  • 16 Iwano M, Neilson E G. Mechanisms of tubulointerstitial fibrosis.  Curr Opin Nephrol Hypertens. 2004;  13 279-284
    PubMedSearch in Google Scholar
  • 17 Bader R, Bader H, Grund K E, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters.  Pathol Res Pract. 1980;  167 204-216
    PubMedSearch in Google Scholar
  • 18 Schainuck L I, Striker G E, Cutler R E, Benditt E P. Structural-functional correlations in renal disease. II. The correlations.  Hum Pathol. 1970;  1 631-641
    CrossrefPubMedSearch in Google Scholar
  • 19 Striker G E, Schainuck L I, Cutler R E, Benditt E P. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease.  Hum Pathol. 1970;  1 615-630
    PubMedSearch in Google Scholar
  • 20 Ha T S, Barnes J L, Stewart J L, Ko C W, Miner J H, Abrahamson D R, Sanes J R, Kasinath B S. Regulation of renal laminin in mice with type II diabetes.  J Am Soc Nephrol. 1999;  10 1931-1939
    PubMedSearch in Google Scholar
  • 21 Miner J H. Developmental biology of glomerular basement membrane components.  Curr Opin Nephrol Hypertens. 1998;  7 13-19
    PubMedSearch in Google Scholar
  • 22 Miner J H. Renal basement membrane components.  Kidney Int. 1999;  56 2016-2024
    CrossrefPubMedSearch in Google Scholar
  • 23 Bruijn J A, Roos A, de Geus B, de Heer E. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.  J Lab Clin Med. 1994;  123 34-47
    PubMedSearch in Google Scholar
  • 24 Brees D K, Hutchison F N, Cole G J, Williams J C. Differential effects of diabetes and glomerulonephritis on glomerular basement membrane composition.  Proc Soc Exp Biol Med. 1996;  212 69-77
    PubMedSearch in Google Scholar
  • 25 Fogo A B. Mesangial matrix modulation and glomerulosclerosis.  Exp Nephrol. 1999;  7 147-159
    CrossrefPubMedSearch in Google Scholar
  • 26 Schnaper H W, Kopp J B. Renal fibrosis.  Front Biosci. 2003;  8 e68-e86
    PubMedSearch in Google Scholar
  • 27 Bergijk E C, Van Alderwegen I E, Baelde H J, de Heer E, Funabiki K, Miyai H, Killen P D, Kalluri R K, Bruijn J A. Differential expression of collagen IV isoforms in experimental glomerulosclerosis.  J Pathol. 1998;  184 307-315
    PubMedSearch in Google Scholar
  • 28 Muchaneta-Kubara E C, el Nahas A M. Myofibroblast phenotypes expression in experimental renal scarring.  Nephrol Dial Transplant. 1997;  12 904-915
    PubMedSearch in Google Scholar
  • 29 Strutz F, Zeisberg M, Ziyadeh F N, Yang C Q, Kalluri R, Muller G A, Neilson E G. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.  Kidney Int. 2002;  61 1714-1728
    CrossrefPubMedSearch in Google Scholar
  • 30 Okada H, Inoue T, Suzuki H, Strutz F, Neilson E G. Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. .  Nephrol Dial Transplant. 2000;  15 Suppl 6 44-46
    PubMedSearch in Google Scholar
  • 31 Okada H, Danoff T M, Kalluri R, Neilson E G. Early role of Fsp1 in epithelial-mesenchymal transformation.  Am J Physiol. 1997;  273 F563-F574
    PubMedSearch in Google Scholar
  • 32 Strutz F, Muller G A, Neilson E G. Transdifferentiation: a new angle on renal fibrosis.  Exp Nephrol. 1996;  4 267-270
    PubMedSearch in Google Scholar
  • 33 Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller G A, Strutz F, Kalluri R. Renal Fibrosis. Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation.  Am J Pathol. 2001;  159 1313-1321
    PubMedSearch in Google Scholar
  • 34 Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.  Am J Pathol. 2001;  159 1465-1475
    PubMedSearch in Google Scholar
  • 35 Stahl P J, Felsen D. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.  Am J Pathol. 2001;  159 1187-1192
    PubMedSearch in Google Scholar
  • 36 Fan J M, Ng Y Y, Hill P A, Nikolic-Paterson D J, Mu W, Atkins R C, Lan H Y. Transforming growth factor-beta regulates tubular epithelial- myofibroblast transdifferentiation in vitro.  Kidney Int. 1999;  56 1455-1467
    CrossrefPubMedSearch in Google Scholar
  • 37 Fan J M, Huang X R, Ng Y Y, Nikolic-Paterson D J, Mu W, Atkins R C, Lan H Y. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.  Am J Kidney Dis. 2001;  37 820-831
    PubMedSearch in Google Scholar
  • 38 Rastaldi M P, Ferrario F, Giardino L, Dell’Antonio G, Grillo C, Grillo P, Strutz F, Muller G A, Colasanti G, D’Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.  Kidney Int. 2002;  62 137-146
    CrossrefPubMedSearch in Google Scholar
  • 39 Lavaud S, Poirier B, Mandet C, Belair M F, Irinopoulou T, Heudes D, Bazin R, Bariety J, Myara I, Chevalier J. Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats.  Am J Physiol Renal Physiol. 2001;  280 F683-F694
    PubMedSearch in Google Scholar
  • 40 Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, Konno Y, Hirata Y, Goto A, Omata M. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis.  Am J Kidney Dis. 1998;  32 419-425
    PubMedSearch in Google Scholar
  • 41 Meyer T W, Anderson S, Rennke H G, Brenner B M. Reversing glomerular hypertension stabilizes established glomerular injury.  Kidney Int. 1987;  31 752-759
    PubMedSearch in Google Scholar
  • 42 Anderson S, Meyer T W, Rennke H G, Brenner B M. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.  J Clin Invest. 1985;  76 612-619
    PubMedSearch in Google Scholar
  • 43 Riser B L, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells.  Curr Opin Nephrol Hypertens. 2000;  9 43-47
    CrossrefPubMedSearch in Google Scholar
  • 44 Riser B L, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, Narins R G. Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells.  Am J Pathol. 1996;  148 1915-1923
    PubMedSearch in Google Scholar
  • 45 Shimamura T, Morrison A B. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats.  Am J Pathol. 1975;  79 95-106
    PubMedSearch in Google Scholar
  • 46 Fine L G, Orphanides C, Norman J T. Progressive renal disease: the chronic hypoxia hypothesis.  Kidney Int Suppl. 1998;  65 S74-S78
    PubMedSearch in Google Scholar
  • 47 Schrijvers B F, De Vriese A S, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.  Endocr Rev. 2004;  25 971-1010
    CrossrefPubMedSearch in Google Scholar
  • 48 Wang S N, LaPage J, Hirschberg R. Glomerular ultrafiltration and apical tubular action of IGF-I, TGF-beta, and HGF in nephrotic syndrome.  Kidney Int. 1999;  56 1247-1251
    CrossrefPubMedSearch in Google Scholar
  • 49 Wang S N, LaPage J, Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.  Kidney Int. 2000;  57 1002-1014
    CrossrefPubMedSearch in Google Scholar
  • 50 Creely J J, DiMari S J, Howe A M, Haralson M A. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells.  Am J Pathol. 1992;  140 45-55
    PubMedSearch in Google Scholar
  • 51 Daniel C, Wiede J, Krutzsch H C, Ribeiro S M, Roberts D D, Murphy-Ullrich J E, Hugo C. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.  Kidney Int. 2004;  65 459-468
    CrossrefPubMedSearch in Google Scholar
  • 52 Ziyadeh F N, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.  J Clin Invest. 1994;  93 536-542
    PubMedSearch in Google Scholar
  • 53 Nakamura T, Miller D, Ruoslahti E, Border W A. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1.  Kidney Int. 1992;  41 1213-1221
    PubMedSearch in Google Scholar
  • 54 Overall C M, Wrana J L, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.  J Biol Chem. 1989;  264 1860-1869
    PubMedSearch in Google Scholar
  • 55 Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill D J, Thomas C R, Sheppard M C, Logan A. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.  Endocrinology. 2000;  141 1196-1208
    CrossrefPubMedSearch in Google Scholar
  • 56 Singh R, Song R H, Alavi N, Pegoraro A A, Singh A K, Leehey D J. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.  Exp Nephrol. 2001;  9 249-257
    CrossrefPubMedSearch in Google Scholar
  • 57 Yamamoto T, Noble N A, Cohen A H, Nast C C, Hishida A, Gold L I, Border W A. Expression of transforming growth factor-beta isoforms in human glomerular diseases.  Kidney Int. 1996;  49 461-469
    CrossrefPubMedSearch in Google Scholar
  • 58 Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K. Quantification of glomerular TGF-b1 mRNA in patients with diabetes mellitus.  Kidney Int. 1996;  49 1120-1126
    PubMedSearch in Google Scholar
  • 59 Sharma K, Ziyadeh F N, Alzahab B, McGowan T A, Kapoor S, Kurnik B RC, Kurnik P B, Weisberg L S. Increased Renal Production of Transforming Growth Factor-b1 in Patients with Type II Diabetes.  Diabetes. 1997;  46 854-859
    PubMedSearch in Google Scholar
  • 60 Shankland S J, Scholey J W, Ly H, Thai K. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy.  Kidney Int. 1994;  46 430-442
    PubMedSearch in Google Scholar
  • 61 Sharma K, Ziyadeh F N. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.  Am J Physiol. 1994;  267 F1094-01
    PubMedSearch in Google Scholar
  • 62 Olsen T S, Orskov H, Lundbaek K. Kidney lesions in rats with severe long-term alloxan diabetes. 2. Histochemical studies, comparison with human diabetic glomerular lesions.  Acta Pathol Microbiol Scand. 1966;  66 1-12
    PubMedSearch in Google Scholar
  • 63 Yang C W, Hattori M, Vlassara H, He C J, Carome M A, Yamato E, Elliot S, Striker G E, Striker L J. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.  J Am Soc Nephrol. 1995;  5 1610-1617
    PubMedSearch in Google Scholar
  • 64 Yamamoto T, Nakamura T, Noble N A, Ruoslahti E, Border W A. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.  Proc Natl Acad Sci U S A. 1993;  90 1814-1818
    PubMedSearch in Google Scholar
  • 65 Bódi I, Kimmel P L, Abraham A A, Svetkey L P, Klotman P E, Kopp J B. Renal TGF-beta in HIV-associated kidney diseases.  Kidney Int. 1997;  51 1568-1577
    PubMedSearch in Google Scholar
  • 66 Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.  Lab Invest. 1993;  68 154-163
    PubMedSearch in Google Scholar
  • 67 Border W A, Yamamoto T, Noble N A. Transforming growth factor beta in diabetic nephropathy.  Diabetes Metab Rev. 1996;  12 309-339
    CrossrefPubMedSearch in Google Scholar
  • 68 Niemir Z I, Stein H, Noronha I L, Krüger C, Andrassy K, Ritz E, Waldherr R. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis.  Kidney Int. 1995;  48 1530-1541
    PubMedSearch in Google Scholar
  • 69 Coimbra T, Wiggins R, Noh J W, Merritt S, Phan S H. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit.  Am J Pathol. 1991;  138 223-234
    PubMedSearch in Google Scholar
  • 70 Yamamoto T, Noble N A, Miller D E, Border W A. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.  Kidney Int. 1994;  45 916-927
    CrossrefPubMedSearch in Google Scholar
  • 71 Border W A, Noble N A. TGF-beta in kidney fibrosis: a target for gene therapy.  Kidney Int. 1997;  51 1388-1396
    PubMedSearch in Google Scholar
  • 72 Border W A, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair.  J Clin Invest. 1992;  90 1-7
    CrossrefPubMedSearch in Google Scholar
  • 73 Wogensen L, Nielsen C B, Hjorth P, Rasmussen L M, Høj Nielsen A, Gross K, Sarvetnick N, Ledet T. Under control of the Renin-1c promoter, Locally, produced transforming growth factor-b1 induces accumulation of glomerular extracellular matrix in transgenic mice.  Diabetes. 1999;  48 182-192
    PubMedSearch in Google Scholar
  • 74 Liu Y. Hepatocyte growth factor and the kidney.  Curr Opin Nephrol Hypertens. 2002;  11 23-30
    CrossrefPubMedSearch in Google Scholar
  • 75 Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.  Am J Physiol Renal Physiol. 2004;  286 F134-F143
    PubMedSearch in Google Scholar
  • 76 Cruzado J M, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, Aran J M, Alperovich G, Vidal A, Grinyo J M. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats.  Diabetes. 2004;  53 1119-1127
    PubMedSearch in Google Scholar
  • 77 Doi T, Striker L J, Quaife C, Conti F G, Palmiter R, Behringer R, Brinster R, Striker G E. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1.  Am J Pathol. 1988;  131 398-403
    PubMedSearch in Google Scholar
  • 78 Doi T, Striker L J, Gibson C C, Agodoa L Y, Brinster R L, Striker G E. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis.  Am J Pathol. 1990;  137 541-552
    PubMedSearch in Google Scholar
  • 79 Doi T, Striker L J, Kimata K, Peten E P, Yamada Y, Striker G E. Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels.  J Exp Med. 1991;  173 1287-1290
    CrossrefPubMedSearch in Google Scholar
  • 80 Kopp J B, Factor V M, Mozes M, Nagy P, Sanderson N, Bottinger E P, Klotman P E, Thorgeirsson S S. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.  Lab Invest. 1996;  74 991-1003
    PubMedSearch in Google Scholar
  • 81 Clouthier D E, Comerford S A, Hammer R E. Hepatic Fibrosis, Glomerulosclerosis, and a Lipodystrophy-like Syndrome in PEPCK-TGF-b1 Transgenic mice.  J Clin Invest. 1997;  100 2697-2713
    CrossrefPubMedSearch in Google Scholar
  • 82 Kopp J B. Glomerulosclerosis, tubulointerstitial fibrosis, and obstructive uropathy in PEPCK-TGF-beta1 transgenic mice.  Am J Kidney Dis. 1999;  34 177-183
    PubMedSearch in Google Scholar
  • 83 Krag S, Østerby R, Chai Q, Nielsen B, Hermans C, Wogensen L. TGF-b1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man.  Lab Invest. 2000;  80 1855-1868
    PubMedSearch in Google Scholar
  • 84 Østerby R. Lesions from kidney biopsies.  Diabetes Metab Rev. 1996;  12 151-174
    CrossrefPubMedSearch in Google Scholar
  • 85 Chai Q, Krag S, Miner J H, Nyengaard J R, Chai S, Wogensen L. TGF-beta1 induces aberrant laminin chain and collagen type IV isotype expression in the glomerular basement membrane.  Nephron Exp Nephrol. 2003;  94 e123-e136
    CrossrefPubMedSearch in Google Scholar
  • 86 Birch N C, Krag S, Osterby R, Flyvbjerg A, Nyengaard J, Forman A, Wogensen L. Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation.  Virchows Arch. 2004;  444 561-566
    PubMedSearch in Google Scholar
  • 87 Chai Q, Krag S, Chai S, Ledet T, Wogensen L. Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta 1-induced renal interstitial fibrosis.  Histochem Cell Biol. 2003;  119 267-280
    PubMedSearch in Google Scholar
  • 88 Cosgrove D, Rodgers K D, Meehan D T, Miller C C, Bovard K, Gilroy A, Gardner H, Koteliansky V, Gotwals P, Amatucci A, Kalluri R. Integrin a1b1 and Transforming growth factor-b1 play distinct roles in Alport glomerular pathogenesis and serve dual targets for metabolic therapy.  Am J Pathol. 2000;  157 1649-1659
    PubMedSearch in Google Scholar
  • 89 Kashtan C E, Kim Y, Lees G E, Thorner P S, Virtanen I, Miner J H. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent.  J Am Soc Nephrol. 2001;  12 252-260
    PubMedSearch in Google Scholar
  • 90 Takeuchi A, Yoshizawa N, Yamamoto M, Sawasaki Y, Oda T, Senoo A, Niwa H, Fuse Y. Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro.  Am J Pathol. 1992;  141 107-116
    PubMedSearch in Google Scholar
  • 91 van Det N F, Verhagen N AM, Tamsma J T, Berden J HM, Bruijn J A, Daha M R, van der Woude F J. Regulation of Glomerular Epithelial Cell Production of Fibronectin and Transforming Growth Factor-b by High Glucose, Not by Angiotensin II.  Diabetes. 1997;  46 834-840
    PubMedSearch in Google Scholar
  • 92 Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, Ramadori G. Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells.  J Hepatol. 1999;  31 692-702
    CrossrefPubMedSearch in Google Scholar
  • 93 MacKay K, Striker L J, Stauffer J W, Doi T, Agodoa L Y, Striker G E. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells.  J Clin Invest. 1989;  83 1160-1167
    PubMedSearch in Google Scholar
  • 94 Bertelli R, Valenti F, Oleggini R, Caridi G, Altieri P, Coviello D A, Botti G, Ravazzolo R, Ghiggeri G M. Cell-specific regulation of alpha1(III) and alpha2(V) collagen by TGF-beta1 in tubulointerstitial cell models.  Nephrol Dial Transplant. 1998;  13 573-579
    PubMedSearch in Google Scholar
  • 95 Han D C, Isono M, Hoffman B B, Ziyadeh F N. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta.  J Am Soc Nephrol. 1999;  10 1891-1899
    PubMedSearch in Google Scholar
  • 96 Le Meur Y, Tesch G H, Rice E, Foti R, Atkins R C, Paterson D JN. Blockade of macrophage accumulation has no effect on renal fibrosis in obstructive nephropathy. Ref Type: Abstract.  J Am Soc Nephrol. 2001;  12 708A
    PubMedSearch in Google Scholar
  • 97 Shankland S J, Johnson R J. TGF-beta in glomerular disease.  Miner Electrolyte Metab. 1998;  24 168-173
    CrossrefPubMedSearch in Google Scholar

Associate Professor Lise Wogensen Bach, D. M. Sci.

The Research Laboratory for Biochemical Pathology · Aarhus University Hospital

44-Noerrebrogade 3B · DK-8000 Aarhus C, Denmark

Phone: +45 89 49 21 67

Fax: +45 89 49 21 50

Email: lwb@ki.au.dk